D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 70 Citations 16,900 224 World Ranking 15452 National Ranking 42

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Psychiatry
  • Schizophrenia

His primary areas of study are Cannabidiol, Psychiatry, Anxiolytic, Anxiety and Anesthesia. His Cannabidiol research incorporates elements of Psychosis, Tetrahydrocannabinol, Neuroscience, Pharmacology and Antipsychotic. His Psychiatry research integrates issues from Psychometrics, Clinical psychology, Parkinson's disease and Neuroprotection.

His study focuses on the intersection of Anxiolytic and fields such as Diazepam with connections in the field of Ipsapirone, Pharmacology toxicology, Drug dosages, Elevated plus maze and Dose–response relationship. His Anxiety study combines topics in areas such as Test and Healthy volunteers. His work in the fields of Sedation overlaps with other areas such as Placebo-controlled study.

His most cited work include:

  • Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. (443 citations)
  • Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients (368 citations)
  • Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients (368 citations)

What are the main themes of his work throughout his whole career to date?

Antonio Waldo Zuardi mainly investigates Cannabidiol, Psychiatry, Pharmacology, Anxiety and Schizophrenia. The study incorporates disciplines such as Antipsychotic, Anesthesia, Internal medicine and Anxiolytic in addition to Cannabidiol. In the subject of general Psychiatry, his work in Brief Psychiatric Rating Scale, Schizophrenic Psychology and Bipolar disorder is often linked to In patient, thereby combining diverse domains of study.

His Pharmacology research includes themes of Tetrahydrocannabinol, Cannabinoid, Endocannabinoid system and Cannabinoid receptor. Antonio Waldo Zuardi has included themes like Clinical psychology, Audiology and Heart rate in his Anxiety study. His Schizophrenia research is multidisciplinary, incorporating perspectives in Psychosis and Neuroscience.

He most often published in these fields:

  • Cannabidiol (59.66%)
  • Psychiatry (32.54%)
  • Pharmacology (32.54%)

What were the highlights of his more recent work (between 2016-2021)?

  • Cannabidiol (59.66%)
  • Pharmacology (32.54%)
  • Internal medicine (15.93%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Cannabidiol, Pharmacology, Internal medicine, Anxiety and Psychiatry. His Cannabidiol study combines topics in areas such as Tetrahydrocannabinol, Anesthesia, Randomized controlled trial and Anxiolytic. The Neuroprotection research Antonio Waldo Zuardi does as part of his general Pharmacology study is frequently linked to other disciplines of science, such as Caspase-9, therefore creating a link between diverse domains of science.

His Internal medicine research incorporates themes from Endocrinology and Epilepsy. His research in Anxiety intersects with topics in Audiology, Depression and Heart rate. In general Psychiatry study, his work on Schizophrenia and Traumatic stress often relates to the realm of Short interval, thereby connecting several areas of interest.

Between 2016 and 2021, his most popular works were:

  • Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life (85 citations)
  • Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life (85 citations)
  • Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. (80 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Psychiatry
  • Schizophrenia

His primary areas of investigation include Cannabidiol, Anesthesia, Anxiety, Internal medicine and Pharmacology. His Cannabidiol study results in a more complete grasp of Cannabis. His Cannabis study is concerned with the larger field of Psychiatry.

His Anesthesia course of study focuses on Anxiolytic and Clonazepam, Sedative, Polysomnography and Antidepressant. His research integrates issues of Blood pressure and Heart rate in his study of Anxiety. His Internal medicine study combines topics from a wide range of disciplines, such as Pilocarpine and Endocrinology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Sagnik Bhattacharyya;Paul D Morrison;Paolo Fusar-Poli;Paolo Fusar-Poli;Rocio Martin-Santos.
Neuropsychopharmacology (2010)

621 Citations

History of cannabis as a medicine: a review

Antonio Waldo Zuardi.
Revista Brasileira de Psiquiatria (2006)

583 Citations

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

Mateus M. Bergamaschi;Regina Helena Costa Queiroz;Regina Helena Costa Queiroz;Marcos Hortes Nisihara Chagas;Marcos Hortes Nisihara Chagas;Danielle Chaves Gomes De Oliveira;Danielle Chaves Gomes De Oliveira.
Neuropsychopharmacology (2011)

572 Citations

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.

A.W. Zuardi;J.A.S. Crippa;J.E.C. Hallak;F.A. Moreira.
Brazilian Journal of Medical and Biological Research (2006)

507 Citations

Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

Paolo Fusar-Poli;José Alexandre de Souza Crippa;Sagnik Bhattacharyya;Stefan J. Borgwardt.
Archives of General Psychiatry (2009)

455 Citations

Cannabis and anxiety: a critical review of the evidence

José Alexandre Crippa;Antonio Waldo Zuardi;Rocio Martín-Santos;Sagnik Bhattacharyya.
Human Psychopharmacology-clinical and Experimental (2009)

453 Citations

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

Antonio Waldo Zuardi.
Revista Brasileira de Psiquiatria (2008)

438 Citations

Safety and side effects of cannabidiol, a Cannabis sativa constituent.

Mateus Machado Bergamaschi;Regina Helena Costa Queiroz;Antonio Waldo Zuardi;José Alexandre de Souza Crippa.
Current Drug Safety (2011)

433 Citations

Alcohol Use Disorders Identification Test (AUDIT): an updated systematic review of psychometric properties

Carolina de Meneses-Gaya;Antonio Waldo Zuardi;Sonia Regina Loureiro;José Alexandre S. Crippa.
Psychology and Neuroscience (2009)

425 Citations

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report:

José Alexandre S Crippa;Guilherme Nogueira Derenusson;Thiago Borduqui Ferrari;Lauro Wichert-Ana.
Journal of Psychopharmacology (2011)

371 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Antonio Waldo Zuardi

José Alexandre de Souza Crippa

José Alexandre de Souza Crippa

Universidade de São Paulo

Publications: 119

Sagnik Bhattacharyya

Sagnik Bhattacharyya

King's College London

Publications: 70

Philip McGuire

Philip McGuire

King's College London

Publications: 52

Tom P. Freeman

Tom P. Freeman

University of Bath

Publications: 45

João Quevedo

João Quevedo

The University of Texas Health Science Center at Houston

Publications: 44

Michael Maes

Michael Maes

Chulalongkorn University

Publications: 39

Norberto Cysne Coimbra

Norberto Cysne Coimbra

Universidade de São Paulo

Publications: 37

Robin M. Murray

Robin M. Murray

King's College London

Publications: 36

Stefan Borgwardt

Stefan Borgwardt

University of Lübeck

Publications: 35

Raphael Mechoulam

Raphael Mechoulam

Hebrew University of Jerusalem

Publications: 34

Deepak Cyril D'Souza

Deepak Cyril D'Souza

Yale University

Publications: 31

Celia J. A. Morgan

Celia J. A. Morgan

University of Exeter

Publications: 29

Marcel O. Bonn-Miller

Marcel O. Bonn-Miller

University of Pennsylvania

Publications: 28

Leonardo F. Fontenelle

Leonardo F. Fontenelle

Monash University

Publications: 27

Iain S. McGregor

Iain S. McGregor

University of Sydney

Publications: 27

Mauro V. Mendlowicz

Mauro V. Mendlowicz

Fluminense Federal University

Publications: 26

Something went wrong. Please try again later.